Characterization of aged osteocalcin fragments derived from bone resorption

Area of Science:

• Biochemistry
• Bone Biology
• Clinical Chemistry

Background:

• Osteocalcin (OC) is a key bone matrix protein.
• Serum/plasma OC levels typically reflect bone formation.
• A novel assay was developed to measure OC fragments in urine.

Purpose of the Study:

• To establish a sensitive assay for quantifying mid-region osteocalcin (OC) fragments in human urine.
• To investigate the relationship between urinary OC fragments and bone resorption markers.
• To characterize the molecular nature of urinary OC fragments.

Main Methods:

• Development of a monoclonal antibody-based inhibition ELISA (Mid-OC Urine ELISA).
• Immunoaffinity and reversed-phase high-performance liquid chromatography for OC fragment isolation and purification.
• N-terminal sequencing and mass spectrometry for molecular characterization.
• Assay validation in bone cell cultures and patient samples.

Main Results:

• Urinary OC fragment release strongly correlated with osteoclast-mediated bone resorption (r²=0.89) and CTX levels (r²=0.91).
• Mid-OC levels significantly decreased following bisphosphonate therapy, confirming its role as a resorption marker.
• Characterization revealed small OC fragments (<15 amino acids) with age-related aspartyl modifications.

Conclusions:

• Osteocalcin fragments are released during osteoclastic bone resorption.
• Quantification of age-modified OC fragments in urine serves as a reliable index of bone resorption.
• This assay provides a new tool for monitoring bone resorption and treatment efficacy.